Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Drugs Made In America Acquisition FCF Yield %?
Drugs Made In America AcquisitionDMAA +0.09%14 FCF Yield % is -0.15 as of Jul. 26, 2026. GuruFocus rates DMAA with a GF Score™ of 14/100. The stock has 1 warning sign investors should review. Among 549 Diversified Financial Services companies, Drugs Made In America Acquisition ranks better than 65.94% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Drugs Made In America Acquisition FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Drugs Made In America Acquisition FCF Yield % Related Terms
Drugs Made In America Acquisition FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Drugs Made In America Acquisition FCF Yield % Chart
For the Shell Companies subindustry, Drugs Made In America Acquisition's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Drugs Made In America Acquisition FCF Yield % vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Drugs Made In America Acquisition's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Drugs Made In America Acquisition's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Drugs Made In America Acquisition (DMAA) has a FCF Yield % of -0.15 as of Jul. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Drugs Made In America Acquisition and its competitors. According to the industry distribution chart, Drugs Made In America Acquisition ranks #187 out of 549 companies in the Diversified Financial Services industry, placing it in the top 34.1%.
Is Drugs Made In America Acquisition's FCF Yield % too high?
Drugs Made In America Acquisition's current FCF Yield % is -0.15. Based on the distribution chart, Drugs Made In America Acquisition ranks #187 out of 549 companies in the Diversified Financial Services industry, which is above the industry midpoint. Overall, Drugs Made In America Acquisition has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition's FCF Yield % compare to PLMK and TRGS?
According to the Diversified Financial Services industry distribution chart, Drugs Made In America Acquisition ranks #187 out of 549 companies for FCF Yield %. This puts Drugs Made In America Acquisition in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Diversified Financial Services company?
A good FCF Yield % depends on the Diversified Financial Services industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Drugs Made In America Acquisition and its competitors. Drugs Made In America Acquisition's current FCF Yield % is -0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition stock overvalued right now?
Drugs Made In America Acquisition (DMAA) has a current FCF Yield % of -0.15. The current FCF Yield % is -0.15. Drugs Made In America Acquisition's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Drugs Made In America Acquisition (DMAA), the current FCF Yield % is -0.15 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Drugs Made In America Acquisition Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DMAA has been successfully added to your 
